SeraCare New Products Posted to GenomeWeb: SomaLogic, LGC SeraCare, LexaGene, More NIST Creating Reference Material for SARS-CoV-2 Diagnostic Assay Developers Premium The agency is providing the material freely and asking for feedback, so it can fix possible problems before more widely disseminating it to labs and companies. New Products Posted to GenomeWeb: LGC SeraCare, Novacyt, OraSure DNA Genotek Private Equity Firms Cinven, Astorg to Acquire LGC LGC provides customers across multiple markets with reference materials, proficiency testing, oligonucleotides, genomics reagents, and instrumentation. New Products Posted to GenomeWeb: SeraCare, Thermo Fisher Scientific, Genome Medical, More May 24, 2019 Multi-Site Study Tests Power of Commercial Reference Materials in Comparing Liquid Biopsy Assays Premium Apr 12, 2019 In Brief This Week: FDA, PreventionGenetics, Twist Bioscience, and More Apr 2, 2019 Bayer, Loxo Next-Generation TRK Inhibitor Shows Promising Activity in AACR Study Premium Nov 26, 2018 LGC Acquires SeraCare Life Sciences, Expands Into Clinical Quality Control Market Oct 29, 2018 SeraCare Inks Deal to Offer AccuRef Reference Materials Oct 26, 2018 New Products Posted to GenomeWeb: MGI, Lucence Diagnostics, SeraCare, More Sep 14, 2018 Survey Finds QC Best Practices in Clinical Genomics Still Developing Jul 27, 2018 New Products Posted to GenomeWeb: SeraCare, Asuragen, Biofortuna, More Apr 20, 2018 In Brief This Week: SeraCare; Human Longevity; CareDx; Interpace Diagnostics; and More Apr 13, 2018 Clinically Validated NGS Assays Miss Challenging But Important Variants, Study Finds Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.